Arch Pediat Adol Med
-
Arch Pediat Adol Med · Apr 2001
Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.
To evaluate the effectiveness of intravenous (IV) ketorolac tromethamine in the treatment of children with sickle cell disease with moderate to severe acute vaso-occlusive pain (VOP) and to develop a predictive model that would determine who would need additional IV analgesics. ⋯ First-line therapy with IV ketorolac and IV fluids resulted in adequate resolution of pain in 53% of episodes with acute VOP. A reported 4 or more painful sites and an initial VAS score greater than 70 were predictors of the likelihood to need additional IV analgesics.
-
Arch Pediat Adol Med · Mar 2001
Comparative StudyAccuracy of a noninvasive temporal artery thermometer for use in infants.
To assess the accuracy of a new noninvasive temporal artery (TA) thermometer in infants; to compare the accuracy of the TA thermometer with that of a tympanic thermometer, using rectal thermometry as the criterion standard; and to compare the tolerability of the TA thermometer with that of the tympanic and rectal thermometers. ⋯ The TA thermometer has limited sensitivity for detecting cases of rectal fever in infants. However, the TA thermometer is more accurate than the tympanic thermometer in infants, and it is better tolerated by infants than rectal thermometry.
-
Arch Pediat Adol Med · Feb 2001
Review Practice Guideline GuidelineConsensus statement for the prevention and management of pain in the newborn.
To develop evidence-based guidelines for preventing or treating neonatal pain and its adverse consequences. Compared with older children and adults, neonates are more sensitive to pain and vulnerable to its long-term effects. Despite the clinical importance of neonatal pain, current medical practices continue to expose infants to repetitive, acute, or prolonged pain. ⋯ Management of pain must be considered an important component of the health care provided to all neonates, regardless of their gestational age or severity of illness.
-
Arch Pediat Adol Med · Feb 2001
Randomized Controlled Trial Clinical TrialThe addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections.
To determine whether the addition of a single dose of ceftriaxone sodium to a 10-day course of trimethoprim and sulfamethoxazole hastens urine sterilization or resolution of clinical symptoms in febrile children with urinary tract infections. ⋯ The addition of a single dose of intramuscular ceftriaxone to a 10-day course of oral trimethoprim-sulfamethoxazole for urinary tract infection with fever resulted in no difference at 48 hours in the urine sterilization rate, degree of clinical improvement, or subsequent hospital admission rate.